Safety and Short-term Efficacy of a Single Dose of 2 mg Moxidectin in Loa loa -Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial With Ascending Microfilarial Densities.

Guy S WafeuTristan M LepageJeremy T CampilloArnauld Efon-EkangouoHugues-Clotaire Nana-DjeungaNarcisse Nzune-TocheAndré DomcheLaurentine SumoGuy-Roger NjitchouangMartine Augusta Flore TsasseJean BopdaYves Aubin BalogYannick Niamsi-EmalioStève Mbickmen-TchanaGervais Kamga TallaYannick Sédrick Nguedia KanaFélicité Diane Maga MessinaSébastien D PionAnnette C KueselJoseph KamgnoMichel BoussinesqCedric B Chesnais

Published in: Open forum infectious diseases (2024)

NCT04049851.

Keyphrases

double blind
open label
placebo controlled
phase iii
clinical trial
phase ii
study protocol
pulmonary artery
drug administration
randomized controlled trial
aortic dissection
coronary artery